RNA urine test outperforms standard bladder cancer tests and could help guide treatment

A simple urine test devised by researchers at Stanford Medicine and the VA Palo Alto Health Care System can diagnose bladder cancer more accurately than current standard methods. The test also allows physicians not only to assess the cancer's response to treatment but also to predict whether immunotherapy or chemotherapy is likely to be most effective for each patient.

The test is unique in that it measures RNA messages shed by tumor cells into urine, rather than hunting for cancer-related mutations in DNA as most blood and urine liquid biopsies do. Because RNA reflects which genes a cancer cell is actively using, it captures a tumor’s behavior in addition to its presence.

“Measuring tumor DNA in urine can tell us whether a cancer is present,” said Maximilian Diehn, M.D., Ph.D., the Jack, Lulu and Sam Willson Professor and a professor of radiation oncology. “Analyzing RNA can tell us not only whether a cancer is present—but also what it’s doing.”

Sign up for Blog Updates